Artificial Intelligence

AI firm DreamzTech Solutions gains major recognition, validating its AI-first strategy and signaling a new wave of Indian tech leaders on the global stage.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

Pure Storage rebrands as Everpure and acquires 1touch, betting its future on providing the intelligent data management layer essential for enterprise AI.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

iRegene Therapeutics hits dual milestones, advancing AI-derived cell therapies for Parkinson's in the US and Multiple System Atrophy in China.

January data shows a massive jump in corporate financing requests, hinting at a busy year for investment, while the municipal market tells a different story.

Light Source Communications is building a massive underground dark fiber network to connect St. Louis and Tulsa, powering the AI revolution in the heartland.

With a soaring stock, $300M in new funding, and strong clinical data, Monte Rosa is set to showcase its novel disease-fighting drug platform.

A new initiative offers biotech firms free access to advanced epiproteomic analysis, aiming to accelerate the development of next-generation precision medicines.

New 12- and 24-month data for Benitec Biopharma's BB-301 gene therapy offers renewed hope for patients with a rare, debilitating muscular dystrophy.

C4 Therapeutics begins a crucial study for its oral protein degrader, cemsidomide, offering new hope for heavily treated multiple myeloma patients.

Anavex Life Sciences adds AMEOS Group CEO Dr. Axel Paeger to its board, a strategic move signaling a push into European markets for its CNS therapies.

With a key drug in trials and a pipeline nearing the clinic, Foghorn Therapeutics brings in a seasoned financial leader to navigate its path to market.

With revenue growth tied to shrinking margins, illumin's upcoming 2025 earnings report is a critical test of its strategy in a shifting ad tech world.

Armed with $320M in new capital, Anteris will showcase its revolutionary biomimetic heart valve to top investors. Can it disrupt a market of giants?

AxyomCore unveils a powerful 4G/5G network extender at MWC, claiming superior coverage and capacity that could disrupt the enterprise connectivity market.

Lenovo unveils a new generation of rugged ThinkEdge devices, moving AI out of the data center to transform manufacturing, retail, and smart cities.

A new partnership brings satellite-powered roadside assistance to Australia's remote areas, offering a critical lifeline for drivers beyond cellular range.

TOMI Environmental Solutions secures crucial biocidal product approvals in Great Britain and NI, paving the way for a major European market expansion.

Vantage Towers and Gridle partner to transform mobile sites into smart energy hubs, boosting resilience, profits, and sustainability. Here's how.